Dr Jerry Greenfield
NHMRC Neil Hamilton Fairley Postdoctoral Research Fellow, Diabetes and Obesity Research Program, Garvan Institute of Medical Research; Conjoint Senior Lecturer, University of New South Wales; Staff Specialist, Department of Endocrinology, St. Vincent’s Hospital; Deputy Director, Diabetes Centre, St. Vincent’s Hospital
Email: j.greenfield 'at' garvan.org.au
Research Group: Greenfield
Education
2005 PhD, University of New South Wales
2001 Fellowship (Endocrinology), Royal Australasian College of Physicians
1995 MBBS (Hons 1) B Sc(Med), University of New South Wales
Awards and honours
2009 NHMRC Project Grant
2008 St. Vincent’s Clinic Foundation Tancred Research Grant
2008 Diabetes Australia Research Trust Grant
2005 NHMRC Neil Hamilton Fairley Postdoctoral Research Fellowship
2005 PhD Thesis Prize, Garvan Institute of Medical Research
2003 Finalist, Pincus Taft Junior Investigator Award for Scientific Presentation by a Junior Scientist at the Annual Scientific Meeting of The Australian Diabetes Society, Melbourne
2002 Finalist, Novartis Award for Scientific Presentation by a Junior Scientist at the Annual Scientific Meeting of The Endocrine Society of Australia, Adelaide
Publications
Greenfield JR, Miller JW, Keogh J, Henning E, Satterwhite JH, Cameron GS, Astruc B, Mayer JP, Brage S, See TC, Lomas DJ, O’Rahilly S, Farooqi IS. Modulation of blood pressure by central melanocortinergic pathways. N Eng J Med 1: 44 – 52 (2009).Greenfield JR, Farooqi IS, Keogh J, Henning E, Habib A, Blackwood A, Reimann F, Holst JJ, Gribble F. Oral glutamine increases circulating GLP-1, glucagon and insulin levels in lean, obese and type 2 diabetic subjects. Am J Clin Nutr 89:1 – 8 (2009).
Greenfield JR, Tuthill A, Soos MA, Semple RK, Halsall DJ, Chaudhry A, O’Rahilly S. Severe insulin resistance due to anti-insulin antibodies: Response to plasma exchange and immunosuppressive therapy. Diabetic Med 26: 79 – 82 (2009).
Greenfield JR, Campbell LV. Role of the autonomic nervous system and neuropeptides in the development of obesity in humans. Curr Pharm Des 14: 1815 – 1820 (2008).
Greenfield JR, Samaras K, Chisholm DJ, Campbell LV. Effect of postprandial insulinemia and insulin resistance on measurement of arterial stiffness (Augmentation Index). Int J Cardiol 114: 50 – 56 (2007).
Greenfield JR, Campbell LV. Relationship between ‘inflammation’, insulin resistance and type 2 diabetes: cause and effect? Curr Diab Rev 2:195-211 (2006).
Greenfield JR, Samaras K, Hayward CS, Chisholm DJ, Campbell LV. Beneficial postprandial effect of a small amount of alcohol on diabetes and cardiovascular risk factors: Modification by insulin resistance. J Clin Endocrinol Metab 90: 661-672 (2005).
Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys, MB, Campbell LV. Obesity is an important determinant of baseline C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109:3022-3028 (2004).
Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Campbell LV. Do gene-environment interactions influence fasting plasma lipids? A study of twins. Eur J Clin Invest 34: 590-598 (2004).
Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 27: 2033-2040 (2004).
Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Campbell LV. Moderate alcohol consumption, dietary fat composition, and abdominal obesity in women: evidence for gene-environment interaction. J Clin Endocrinol Metabol 88: 5381-5386 (2003).
Greenfield JR, Samaras K, Campbell LV, Jenkins AJ, Kelly PJ, Spector TD, Hayward CS. Physical activity reduces genetic susceptibility to increased central systolic pressure augmentation: A study of female twins. J Am Coll Cardiol 42:264-270 (2003).
Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Campbell LV. Moderate alcohol consumption, estrogen replacement therapy and physical activity are associated with increased insulin sensitivity: Is abdominal adiposity the mediator? Diabetes Care 26:2734-2740 (2003).
Greenfield JR, Samaras K, Chisholm DJ, Campbell LV. Regional intra-subject variability in abdominal adiposity limits usefulness of computed tomography. Obesity Res 10: 260-5 (2002).
Greenfield JR, Samaras K, Chisholm DJ. Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes. J Clin Endocrinol Metab 87:1036-40 (2002).
Search for all publications by Jerry Greenfield
.
